Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.235 USD | +2.04% | -4.59% | -9.57% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 544M 45.39B |
---|---|---|---|---|---|
Net income 2024 * | -123M -10.26B | Net income 2025 * | -148M -12.35B | EV / Sales 2024 * | - |
Net cash position 2024 * | 267M 22.27B | Net cash position 2025 * | 153M 12.76B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.42
x | P/E ratio 2025 * |
-4.08
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.54% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +2.35% | ||
1 week | -4.59% | ||
Current month | -39.49% | ||
1 month | -35.65% | ||
3 months | -28.95% | ||
6 months | +30.61% | ||
Current year | -9.57% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 07/18/07 |
Richard Heyman
FOU | Founder | 66 | 01/14/01 |
Director of Finance/CFO | 50 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 09/21/09 |
Richard Heyman
FOU | Founder | 66 | 01/14/01 |
Mardi Dier
BRD | Director/Board Member | 60 | 02/20/02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 8.34 | +3.35% | 41 860 |
26/24/26 | 8.07 | +5.22% | 401,565 |
25/24/25 | 7.67 | -5.07% | 636,172 |
24/24/24 | 8.08 | -7.87% | 374,881 |
23/24/23 | 8.77 | +0.57% | 270,485 |
Delayed Quote Nasdaq, April 29, 2024 at 07:57 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.57% | 544M | |
-2.19% | 103B | |
+1.41% | 95.28B | |
+2.59% | 22.15B | |
-15.87% | 21.02B | |
-8.35% | 18.15B | |
-41.01% | 16.73B | |
-13.89% | 16.05B | |
+3.95% | 13.68B | |
+34.71% | 12.17B |
- Stock Market
- Equities
- ORIC Stock